Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Advancement in the Development of DNA Vaccines Against Trypanosoma brucei and Future Perspective

Version 1 : Received: 27 July 2023 / Approved: 27 July 2023 / Online: 28 July 2023 (02:27:14 CEST)

How to cite: Alouffi, A.; Munir, F.; Sindhu, Z.U.D.; Almutairi, M.M.; Aleem, M.T. Advancement in the Development of DNA Vaccines Against Trypanosoma brucei and Future Perspective. Preprints 2023, 2023071900. https://doi.org/10.20944/preprints202307.1900.v1 Alouffi, A.; Munir, F.; Sindhu, Z.U.D.; Almutairi, M.M.; Aleem, M.T. Advancement in the Development of DNA Vaccines Against Trypanosoma brucei and Future Perspective. Preprints 2023, 2023071900. https://doi.org/10.20944/preprints202307.1900.v1

Abstract

Trypanosomes are the extracellular protozoan parasites that cause human African trypanosomiasis disease in humans and nagana disease in animals. The disease is endemic in African countries where tsetse flies which act as a vector for the transmission of disease are present. The animals infected by these parasites become useless or workless and disease can become fatal if not treated. Old drugs used for treatment have many side effects and some are responsible for death in 5% of the patients. The parasite possesses a major surface protein known as variant surface glycoprotein. The immune system of the host develops antibodies against this antigen but due to antigenic variation, parasites evade the immune response. Currently, no vaccine is available that provides complete protection. Only partial protection using certain antigens in murine models was investigated. The tools of molecular biology and immunology have enabled a novel approach to the development of vaccines against trypanosomes. Immunization is the sole method for the control of disease because the eradication of the vector from endemic areas is an impossible task. Genetic vaccines can carry multiple genes encoding different antigens of the same parasite or different parasites. DNA immunization induces the activation of both cellular immune response and humoral immune response along with the generation of memory. This review highlights the importance of DNA vaccines and advances in the development of DNA vaccines against T. brucei.

Keywords

DNA vaccine; delivery system, variant surface glycoprotein; nanoparticle; antigenic variation; endemic

Subject

Biology and Life Sciences, Animal Science, Veterinary Science and Zoology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.